Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma
ZUMA-1 的五年随访结果支持 axicabtagene ciloleucel 在难治性大 B 细胞淋巴瘤中的治愈潜力
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2022018893
Neelapu, Sattva S; Jacobson, Caron A; Ghobadi, Armin; Miklos, David B; Lekakis, Lazaros J; Oluwole, Olalekan O; Lin, Yi; Braunschweig, Ira; Hill, Brian T; Timmerman, John M; Deol, Abhinav; Reagan, Patrick M; Stiff, Patrick; Flinn, Ian W; Farooq, Umar; Goy, Andre H; McSweeney, Peter A; Munoz, Javier; Siddiqi, Tanya; Chavez, Julio C; Herrera, Alex F; Bartlett, Nancy L; Bot, Adrian A; Shen, Rhine R; Dong, Jinghui; Singh, Kanwarjit; Miao, Harry; Kim, Jenny J; Zheng, Yan; Locke, Frederick L